Keyphrases
Liver Transplantation
100%
Acute Liver Failure
67%
Hepatitis C Virus
49%
Orthotopic Liver Transplantation
39%
Liver Transplant Recipients
38%
Hepatitis C
29%
Transplantation
29%
Chronic Hepatitis C
27%
Hepatocellular Carcinoma
27%
Interferon-α (IFN-α)
25%
Cirrhosis
23%
Liver
19%
Primary Biliary Cirrhosis
18%
Patient Survival
18%
Etiology
17%
Primary Sclerosing Cholangitis
15%
Ribavirin
15%
United States
14%
Pretransplant
14%
Cholestatic Liver Disease
13%
MELD Score
13%
Acetaminophen
13%
Fibrosis
13%
Virus-specific
13%
Immunosuppression
12%
Allograft
12%
End-stage Liver Disease
11%
MicroRNA
10%
Hepatitis B Virus
10%
Graft Survival
10%
Hepatitis
10%
Liver Allograft
9%
Risk Factors
9%
Survival Rate
9%
Recurrent Hepatitis
8%
Infected Patients
8%
Liver Disease
8%
Solid Organ Transplantation
8%
Cirrhotic Liver
8%
Antiretroviral Therapy
8%
Immune Response
7%
Hepatitis C Virus Infection
7%
Chronic Liver Disease
7%
Alpha-fetoprotein
7%
Bone Disease
7%
Prognostic Model
7%
Autoimmune Hepatitis
7%
CD4+
7%
Hepatitis C Recurrence
7%
Retransplantation
6%
Medicine and Dentistry
Liver Transplantation
93%
Liver Graft
50%
Acute Liver Failure
48%
Transplantation
34%
Hepatitis C
28%
Liver Disease
26%
Hepatocellular Carcinoma
26%
Hepatitis C Virus
23%
Disease
22%
Recurrent Disease
20%
Liver Cirrhosis
20%
Allograft
19%
Primary Biliary Cirrhosis
17%
Primary Sclerosing Cholangitis
15%
Ribavirin
13%
Paracetamol
13%
Infection
12%
End Stage Liver Disease
11%
Chronic Hepatitis C
10%
Immunosuppressive Treatment
10%
Graft Survival
9%
Hepatitis B Virus
9%
Neoplasm
8%
Hepatitis B
8%
Transcatheter Arterial Chemoembolization
7%
Fibrosis
7%
Alpha-Fetoprotein
7%
Bone Disease
7%
Model For End Stage Liver Disease Score
7%
Peginterferon
6%
Liver Injury
6%
Biopsy Technique
6%
Bone Density
6%
Lumbar Spine
6%
Diagnosis
6%
Retransplantation
6%
Combination Therapy
6%
Interferon
6%
Chronic Liver Disease
6%
Antiviral Therapy
6%
Liver Failure
6%
Survival Rate
5%
Hepatitis A
5%
Model for End-Stage Liver Disease
5%
Wilson's Disease
5%
Long Term Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Liver Failure
54%
Hepatitis C
32%
Hepatitis C Virus
25%
Paracetamol
21%
Chronic Hepatitis C
18%
Ribavirin
15%
Recurrent Disease
14%
Interferon
14%
Liver Disease
14%
Liver Cell Carcinoma
14%
End Stage Liver Disease
13%
microRNA
13%
Infection
12%
Disease
10%
Survival Rate
9%
Liver Cirrhosis
9%
Fibrosis
9%
Liver Injury
8%
Neoplasm
8%
Hepatitis B Virus
8%
Cohort Study
7%
Ethanol
7%
Primary Biliary Cirrhosis
7%
Peginterferon
6%
Injury
6%
Hepatitis B
6%
HIV
6%
Vitamin D-Binding Protein
6%
Lamivudine
6%
Chronic Hepatitis B
6%
Isoniazid
6%
Tacrolimus
6%
Ciclosporin
6%
Ursodeoxycholic Acid
6%
Alpha Interferon
6%
Tolerability
6%
Virus Hepatitis
6%
Antiviral Therapy
6%
Hepatitis A
5%
Alpha2b Interferon
5%
Wilson's Disease
5%
Liver Failure
5%
Inflammation
5%
Autoimmune Hepatitis
5%